Paramora Holding LLC Reduces Stake in Damora Therapeutics, Inc. Below 5% Threshold

On April 23, 2026, Paramora Holding LLC filed an amendment to its Schedule 13G (Amendment No. 1) regarding its holdings in Damora Therapeutics, Inc. (ticker: GLTO). The filing indicates that as of the event date on February 9, 2026, Paramora Holding LLC beneficially owns 2,045,473 shares of common stock. This position represents approximately 3.39% of the issuer's outstanding shares, based on a total of 60,303,212 shares reported as of March 17, 2026. The reporting person has sole voting and dispositive power over all 2,045,473 shares. Notably, this filing serves to report that the filer has ceased to be the beneficial owner of more than five percent of the class of securities, as indicated by the 'Yes' flag in Item 5. The filing was made under Rule 13d-1(c), certifying that the securities were not acquired for the purpose of changing or influencing the control of the issuer. Paramora Holding LLC is a Delaware-based entity with principal offices in Waltham, Massachusetts.